T
464280
vs
K
KOSPI 200
Over the past 12 months, TDSPharm Co Ltd has underperformed KOSPI 200, delivering a return of -39% compared to KOSPI 200's +150% growth.
Stocks Performance
464280 vs KOSPI 200
Performance Gap
464280 vs KOSPI 200
Performance By Year
464280 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
TDSPharm Co Ltd
Glance View
TDSPharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines. It earns money mainly by selling finished drug products, either directly or through distributors, to the healthcare market. Its customers are typically hospitals, clinics, pharmacies, and other medicine buyers that need reliable supply of approved drugs. The company’s role is to turn drug formulas and manufacturing know-how into products that can be sold through the regulated pharmaceutical supply chain. What makes this business model different is that it depends on trust, regulation, and steady product supply rather than consumer branding. In plain terms, TDSPharm sits in the middle of the medicine value chain: it produces the drugs that doctors and pharmacies use, then gets paid each time those products move into the market.
